Indonesia documents

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for HPV Demo support: Indonesia

Date of Gavi approval: 17 June 2016

Proposal for NVS - JE, MR support: Indonesia

Date of Gavi approval: 17 June 2016

Proposal for NVS - IPV support 2016: Indonesia

Date of Gavi approval: 27 April 2016

Proposal for NVS - Penta support: Indonesia

Date of Gavi approval: 12 April 2012

Proposal for ISS support: Indonesia

Date of Gavi approval: 24 July 2008

Proposal for CSO support: Indonesia

Date of Gavi approval: 17 July 2008

Proposal for HSS support: Indonesia

Date of Gavi approval: 17 July 2008

Proposal for ISS support: Indonesia (2003)

Date of Gavi approval: 01 June 2003

Proposal and clarifications for NVS - HepB support: Indonesia

Date of Gavi approval: 16 January 2002

Comprehensive multi-year plans/Financial sustainability plans

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive multi-year plan for -2010-2014

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Indonesia

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision Letter Devices Indonesia 2017

Decision Letter NVS Indonesia 2017

Decision Letter NVS Indonesia 2016 (5)

Decision Letter NVS Indonesia 2016 (6)

Decision Letter NVS Indonesia 2016 (4)

Decision Letter NVS Indonesia 2016 (3)

Decision Letter NVS Indonesia 2016 (2)

Decision Letter NVS Indonesia 2016

Decision letter NVS Indonesia 2015

Decision Letter HSS Indonesia 2015

Decision Letter - Indonesia HPV Devices Year 2

Partnership Framework Agreement Indonesia

Decision Letter NVS Indonesia 2018

Decision letter NVS Indonesia 2014(2)

Decision Letter Devices Indonesia 2017 (3)

Decision Letter NVS Indonesia 2014

Decision Letter NVS Indonesia 2017 (3)

Decision letter NVS Indonesia 2013

Decision Letter Devices Indonesia 2017 (2)

Decision letter HSS Indonesia 2013

Decision letter NVS Indonesia 2013 (2)

Decision Letter NVS Indonesia 2017 (2)

The joint appraisal report

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

Joint Appraisal Indonesia 2017

Joint Appraisal Indonesia 2016

Joint Appraisal Indonesia 2015

Joint Appraisal Indonesia 2014

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted country assistance plan Indonesia 2018

Targeted country assistance plan Indonesia 2017

Annual progress reports

All eligible countries are invited to submit proposals for Gavi support. 

Annual Progress Report Indonesia 2008

Annual progress report Indonesia 2007

Annual progress report Indonesia 2006

Annual progress report Indonesia 2004

Annual progress report Indonesia 2005

Annual progress report Indonesia 2003

Annual progress report Indonesia 2002

Annual progress report Indonesia 2001

Annual progress report Indonesia 2014

Annual progress report Indonesia 2013

Annual progress report Indonesia 2012

Annual progress report Indonesia 2011

Annual progress report Indonesia 2010

Annual progress report Indonesia 2009

Subscribe to our newsletter